EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early Inflammatory Biomarkers, Ventricular Dysfunction and In-Hospital Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Dan Claudiu Magureanu iD, Maria Luiza Hiceag, Camelia Bianca Rus iD, Timea Claudia Ghitea iD, Corina Cinezan iD

Diagnostics · 25.06.2026 · 16 (13) · 1978

DOI: 10.3390/diagnostics16131978 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 25.06.2026. Verfasst von Dan Claudiu Magureanu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oradea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Inflammation plays a central role in the pathophysiology of ST-elevation myocardial infarction (STEMI) and may influence myocardial injury, ventricular dysfunction and clinical outcomes. Simple inflammatory biomarkers derived from routine laboratory tests have been proposed as potential prognostic indicators in patients undergoing primary percutaneous coronary intervention (PCI).

Objective

This study aimed to evaluate the association between admission inflammatory biomarkers, echocardiographic markers of ventricular dysfunction and in-hospital mortality in patients with STEMI treated with primary PCI.

Methods

We conducted a retrospective observational study including 600 consecutive patients admitted with STEMI and treated with primary PCI between January 2021 and August 2025. Inflammatory biomarkers measured at admission included C-reactive protein (CRP); neutrophil-to-lymphocyte ratio (NLR); platelet-to-lymphocyte ratio (PLR); systemic immune-inflammation index (SII) and C-reactive protein-to-lymphocyte ratio (CLR). Echocardiographic parameters and clinical outcomes were recorded. Multivariable logistic regression analysis was performed to identify independent predictors of in-hospital mortality.

Results

In-hospital mortality occurred in 54 patients (9.0%). Patients with reduced left ventricular ejection fraction (LVEF ≤ 40%) had significantly higher CRP and CLR levels (p < 0.01). Inflammatory biomarkers were associated with markers of ventricular dysfunction but were not independent predictors of mortality. Age, LVEF < 40% and the number of residual coronary lesions independently predicted in-hospital death.

Conclusions

In STEMI patients undergoing primary PCI, early mortality is mainly determined by age; ventricular dysfunction and residual coronary disease burden, while inflammatory biomarkers primarily reflect the severity of myocardial injury rather than independently predicting short-term mortality.

Schlagwörter

Stichwörter der Autor:innen

C-reactive proteinST-elevation myocardial infarctionin-hospital mortalityinflammatory biomarkersleft ventricular ejection fractionneutrophil-to-lymphocyte ratioprimary percutaneous coronary interventionventricular dysfunction

Autor:innen und Institutionen

  • Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Cardiology Department, Niculae Stancioiu Heart Institute, 400001 Cluj-Napoca, Romania.
  • Cardiology Department, Rehabilitation Hospital, 400347 Cluj-Napoca, Romania.
  • Cardiology Department, Municipal Hospital Aiud, 515200 Aiud, Romania.
  • Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
  • Clinical County Emergency Hospital Bihor, 410169 Oradea, Romania.

ORCID-Profile: Dan Claudiu Magureanu, Camelia Bianca Rus, Timea Claudia Ghitea, Corina Cinezan

Förderung

  • University of Oradea

Zitieren

APA

Magureanu, D. C., Hiceag, M. L., Rus, C. B., Ghitea, T. C., & Cinezan, C. (2026). Early Inflammatory Biomarkers, Ventricular Dysfunction and In-Hospital Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Diagnostics, 16(13), 1978. https://doi.org/10.3390/diagnostics16131978

Vancouver

Magureanu DC, Hiceag ML, Rus CB, Ghitea TC, Cinezan C. Early Inflammatory Biomarkers, Ventricular Dysfunction and In-Hospital Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Diagnostics. 2026;16(13):1978. doi:10.3390/diagnostics16131978

BibTeX
@article{Magureanu2026,
  author = {Magureanu, Dan Claudiu and Hiceag, Maria Luiza and Rus, Camelia Bianca and Ghitea, Timea Claudia and Cinezan, Corina},
  title = {Early Inflammatory Biomarkers, Ventricular Dysfunction and In-Hospital Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {13},
  pages = {1978},
  doi = {10.3390/diagnostics16131978}
}
Kostenlos starten →